Key facts
- Cambridge Medical Technologies’s last known valuation is $88.0M.
- It has raised $28.0M; the latest was Later Stage VC ($18.2M) in Jun 2024.
- Notable investors include 24Haymarket, Cadence Venture Capital, Crimson Phoenix, Kayan Ventures, Massar International — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Cambridge Medical Technologies
- ·The full record, as it builds
Funding rounds
No funding rounds for Cambridge Medical Technologies are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cambridge Medical Technologies
Manufacturer of medical devices designed to obtain regular clinical-grade readings of blood biomarkers. The company's nano-scale fluid sampling and testing systems electrochemically detect blood analytes present in the interstitial fluid, enabling healthcare providers to make informed decisions and monitor patient progress effectively.
- Sector
- Healthcare
- HQ
- Cambridge, United Kingdom
- Founded
- 2014
- Employees
- 13
- Website
- cambridgemedtech.com/
- Ownership
- Privately Held (backing)
Cambridge Medical Technologies doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cambridge Medical Technologies shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cambridge Medical Technologies in its N-PORT filings yet. We sweep new filings monthly.